Phase II Study of High Dose Cyclophosphamide, Mitoxantrone, and Carboplatin With Autologous Bone Marrow Transplantation in Refractory or Relapsed Ovarian Carcinoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carboplatin; Cyclophosphamide; Mitoxantrone
- Indications Ovarian cancer
- Focus Therapeutic Use
- 30 May 2013 Biomarkers information updated
- 15 Aug 2005 New trial record.